Globus Medical, Inc.
Globus Medical, Inc.
Your view on GMED
Overview
What the company does, where it operates, and who runs it.
About Globus Medical, Inc.
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Keith W. Pfeil
- Headquarters
- 2560 General Armistead Avenue, Audubon, PA, US
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Keith W. Pfeil
- Headquarters
- 2560 General Armistead Avenue, Audubon, PA, US
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally.
It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives.
The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants.
In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
Fair value for Globus Medical, Inc. from FRC's valuation model, read against the market price. GMED last traded at $72.30, 17.6× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Globus Medical, Inc.. Starting points for Globus Medical, Inc.: P/E 17.6, EPS $4.16, beta 0.96 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Globus Medical, Inc.. Globus Medical, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Globus Medical, Inc.. Trailing twelve-month EPS for Globus Medical, Inc. stands at $4.16. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
1-Year Price Target
Low
$78.00
Median
$83.50
High
$100.00
Average target · 1 new target in the last month, average $78.00
Analyst Ratings
- Strong Buy0
- Buy26
- Hold10
- Sell1
- Strong Sell0
Earnings Estimate
| EPS | Current QtrDec 2026 | Next QtrMar 2027 | Current YearFY Dec 2026 | Next YearFY Dec 2027 |
|---|---|---|---|---|
| Avg. estimate | $1.29 | $1.20 | $4.98 | $5.36 |
| Low estimate | $1.22 | $1.17 | $4.96 | $5.03 |
| High estimate | $1.32 | $1.25 | $5.17 | $5.57 |
| No. of analysts | 9 | 6 | 9 | 9 |
| Year-ago EPS | $1.01 | $0.90 | $3.92 | — |
| Growth | +27.8% | +33.2% | +27.0% | — |
Revenue Estimate
| Revenue | Current QtrDec 2026 | Next QtrMar 2027 | Current YearFY Dec 2026 | Next YearFY Dec 2027 |
|---|---|---|---|---|
| Avg. estimate | $789.12M | $773.94M | $3.11B | $3.28B |
| Low estimate | $784.05M | $770.90M | $3.10B | $3.25B |
| High estimate | $798.69M | $775.83M | $3.12B | $3.31B |
| No. of analysts | 9 | 5 | 11 | 11 |
| Year-ago revenue | $826.39M | $759.85M | $2.94B | — |
| Growth | -4.5% | +1.9% | +5.8% | — |
Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep from StreetInsider, Benzinga; as of Nov 13, 2026. Not FRC research or a recommendation.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Globus Medical, Inc.. Globus Medical, Inc. has reported as a listed company since 2012. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Globus Medical, Inc. valued side by side against its closest peers. Globus Medical, Inc. is measured against Medical - Devices peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
Which funds and firms own the stock.
Which institutions hold Globus Medical, Inc., and how their positions are changing. At a $9.71B market value, institutional positions materially move Globus Medical, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
Buying and selling by Globus Medical, Inc. executives and directors. Shares of Globus Medical, Inc. have traded between $51.79 and $94.93 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Globus Medical, Inc.. Globus Medical, Inc. is a $9.71B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.
House Trading
U.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Globus Medical, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Globus Medical, Inc.. Coverage tracks Globus Medical, Inc. within Medical - Devices (Healthcare). Press releases and market coverage, newest first.
Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Globus Medical, Inc.